September 30, 2021

拉霍亚—索尔克助理教授 Graham McVicker has been awarded a National Human Genome Research Institute (NHGRI) Genomic Innovator Award, which supports early-career scientists who conduct innovative, creative research in genomics. The award, which provides $2.85 million over five years, is in recognition of McVicker’s efforts using computational and experimental approaches to investigate how human genetic diversity leads to metabolic, cardiovascular, autoimmune and other diseases.
“Graham is pushing the boundaries of computational genetics as he unravels the molecular drivers of disease states,” says Salk President and Professor 鲁斯蒂·盖奇. “We are thrilled to see Graham get recognized for his talent and contributions to the field of genomics.”
McVicker, who holds the Frederick B. Rentschler Developmental Chair, studies how differences in human DNA (genetic variants) affect gene regulation in order to understand the genetic underpinnings of complex human diseases. He seeks to identify the disease-associated regulatory variants that act in a variety of cell types, including immune cells, neuronal cells and cancer cells. Currently, he is utilizing a combination of technologies for altering genes and computational analyses to discover regulatory sequences, interpret genetic variants that do not code for proteins and connect them to the genes they regulate. In much of his research, he develops sophisticated computational and statistical methods to extract subtle signals from experimental data.
宣传办公室
电话:(858) 453-4100
press@salk.edu
萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.